Lipopolysaccharide-induced active telocyte exosomes alleviate lipopolysaccharide-induced vascular barrier disruption and acute lung injury via the activation of the miRNA-146a-5p/caspase-3 signaling pathway in endothelial cells

Abstract

Background: Lipopolysaccharide (LPS)-induced apoptosis of lung microvascular endothelial cells (ECs) is the main reason of lung edema and acute lung injury (ALI) in septic conditions. Telocytes (TCs) are a distinct type of interstitial cells found around the lung microvasculature, which may protect ECs through the release of shed vesicles. However, whether TCs protect against LPS-induced EC apoptosis and ALI has not been determined. Methods: The protective effects of TCs on ECs were assessed in vitro using transwell assays and flow cytometry, and in vivo using an LPS-induced mouse ALI model. RNA sequencing was used to identify miRNA-146a-5p as a key component of TC-derived exosomes. The functions of miRNA-146a-5p were further evaluated by western blotting, flow cytometry, and transendothelial electrical resistance measurements. Results: We demonstrated that LPS stimulation induced the secretion of active exosomes from TCs, which inhibited LPS-mediated apoptosis of ECs and reduced ALI in mice. Moreover, miRNA-146a-5p was identified as the main bioactive molecule in TC-derived exosomes, capable of inhibiting LPS-induced caspase-3 activation and apoptosis in ECs. Conclusions: Our results indicate that TCs effectively prevent LPS-induced EC apoptosis and ALI through the release of exosomes, with subsequent activation of the miRNA-146a-5p/caspase-3 signaling pathway in ECs.

Keywords

Telocyte / Endothelial cells / Acute lung injury / Sepsis / miRNA-146 / Organ dysfunction syndrome / Lipopolysaccharide / LPS

References

[1] Font MD, Thyagarajan B, Khanna AK. Sepsis and septic shock-basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am 2020; 104: 573-85. https://doi.org/10.1016/j.mcna.2020.02.011.

[2] Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res 2022; 9: 56. https://doi.org/10.1186/s40779-022-00422-y.

[3] Guo F, Tang J, Zhou Z, Dou Y, Van Lonkhuyzen D, Gao C, et al. GEF-H1-RhoA signaling pathway mediates LPS-induced NF-kappaB transactivation and IL-8 synthesis in endothelial cells. Mol Immunol 2012; 50: 98-107. https://doi.org/10.1016/j.molimm.2011.12.009.

[4] Yi L, Huang X, Guo F, Zhou Z, Chang M, Tang J, et al. Lipopolysaccharide induces human pulmonary micro-vascular endothelial apoptosis via the YAP signaling pathway. Front Cell Infect Microbiol 2016; 6: 133. https://doi.org/10.3389/fcimb.2016.00133.

[5] Hou X, Yang S, Yin J. Blocking the REDD1/TXNIP axis ameliorates LPS-induced vascular endothelial cell injury through repressing oxidative stress and apoptosis. Am J Physiol Cell Physiol 2019; 316: C104-10. https://doi.org/10.1152/ajpcell.00313.2018.

[6] Guo J, Chen W, Bao B, Zhang D, Pan J, Zhang M. Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms. Bioengineered 2021; 12: 1324-37. https://doi.org/10.1080/21655979.2021.1915671.

[7] Duan X, Yang Y, Yang A, Zhao Y, Fan F, Niu L, et al. Terbutaline attenuates LPS-induced injury of pulmonary microvascular endothelial cells by cAMP/Epac signaling. Drug Dev Res 2022; 83: 699-707. https://doi.org/10.1002/ddr.21901.

[8] Opal SM, van der Poll T. Endothelial barrier dysfunction in septic shock. J Intern Med 2015; 277: 277-93. https://doi.org/10.1111/joim.12331.

[9] Mu S, Liu Y, Jiang J, Ding R, Li X, Li X, et al. Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury. Respir Res 2018; 19: 220. https://doi.org/10.1186/s12931-018-0925-6.

[10] Zhou Z, Guo F, Yi L, Tang J, Dou Y, Huan J. The p38/mitogen-activated protein kinase pathway is implicated in lipopolysaccharide-induced microtubule depolymerization via upregulation of microtubule-associated protein 4 phosphorylation in human vascular endothelium. Surgery 2015; 157: 590-8. https://doi.org/10.1016/j.surg.2014.10.007.

[11] Yi L, Huang X, Guo F, Zhou Z, Chang M, Huan J. GSK-3Beta-dependent activation of GEF-H1/ROCK signaling promotes LPS-induced lung vascular endothelial barrier dysfunction and acute lung injury. Front Cell Infect Microbiol 2017; 7: 357. https://doi.org/10.3389/fcimb.2017.00357.

[12] Dutra Silva J, Su Y, Calfee CS, Delucchi KL, Weiss D, McAuley DF, et al. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS. Eur Respir J 2021; 58: 2002978. https://doi.org/10.1183/13993003.02978-2020.

[13] Popescu LM, Gherghiceanu M, Suciu LC, Manole CG, Hinescu ME. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res 2011; 345: 391-403. https://doi.org/10.1007/s00441-011-1229-z.

[14] Song D, Xu M, Qi R, Ma R, Zhou Y, Wu D, et al. Influence of gene modification in biological behaviors and responses of mouse lung telocytes to inflammation. J Transl Med 2019; 17: 158. https://doi.org/10.1186/s12967-019-1870-y.

[15] Wollheim FA. Telocytes, communicators in healthy stroma and relation to inflammation and fibrosis. Joint Bone Spine 2016; 83: 615-8. https://doi.org/10.1016/j.jbspin.2016.06.002.

[16] Cretoiu SM. Telocytes and other interstitial cells: from structure to function. Int J Mol Sci 2021; 22: 5271. https://doi.org/10.3390/ijms22105271.

[17] Yang J, Li Y, Xue F, Liu W, Zhang S. Exosomes derived from cardiac telocytes exert positive effects on endothelial cells. Am J Transl Res 2017; 9: 5375-87.

[18] Aschacher T, Aschacher O, Schmidt K, Enzmann FK, Eichmair E, Winkler B, et al. The role of telocytes and telocyte-derived exosomes in the development of thoracic aortic aneurysm. Int J Mol Sci 2022; 23: 4730. https://doi.org/10.3390/ijms23094730.

[19] Tang L, Song D, Qi R, Zhu B, Wang X. Roles of pulmonary telocytes in airway epithelia to benefit experimental acute lung injury through production of telocyte-driven mediators and exosomes. Cell Biol Toxicol 2023; 39: 451-65. https://doi.org/10.1007/s10565-021-09670-5.

[20] Zhang C, Guo F, Chang M, Zhou Z, Yi L, Gao C, et al. Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-κB signaling axis and glycocalyx enhancement. Exp Cell Res 2019; 384: 111596. https://doi.org/10.1016/j.yexcr.2019.111596.

[21] Popescu LM, Faussone-Pellegrini MS. TELOCYTES-a case of serendipity: the winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to TELOCYTES. J Cell Mol Med 2010; 14: 729-40. https://doi.org/10.1111/j.1582-4934.2010.01059.x.

[22] Cantarero I, Luesma MJ, Junquera C. The primary cilium of telocytes in the vasculature: electron microscope imaging. J Cell Mol Med 2011; 15: 2594-600. https://doi.org/10.1111/j.1582-4934.2011.01312.x.

[23] Cretoiu D, Xu J, Xiao J, Cretoiu SM. Telocytes and their extracellular vesicles-evidence and hypotheses. Int J Mol Sci 2016; 17: 1322. https://doi.org/10.3390/ijms17081322.

[24] Li J, Huang J, Dai L, Yu D, Chen Q, Zhang X, et al. miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther 2012; 14: R75. https://doi.org/10.1186/ar3798.

[25] Wang S, Yang Y, Suen A, Zhu J, Williams B, Hu J, et al. Role of extracellular microRNA-146a-5p in host innate immunity and bacterial sepsis. iScience 2021; 24: 103441. https://doi.org/10.1016/j.isci.2021.103441.

[26] Yi L, Chang M, Zhao Q, Zhou Z, Huang X, Guo F, et al. Genistein-3′-sodium sulphonate protects against lipopolysaccharide-induced lung vascular endothelial cell apoptosis and acute lung injury via BCL-2 signalling. J Cell Mol Med 2020; 24: 1022-35. https://doi.org/10.1111/jcmm.14815.

[27] Yi L, Zhou Z, Zheng Y, Chang M, Huang X, Guo F, et al. Suppressive effects of GSS on lipopolysaccharide-induced endothelial cell injury and ALI via TNF-α and IL-6. Mediat Inflamm 2019; 2019: 1-13. https://doi.org/10.1155/2019/4251394.

[28] Bei Y, Zhou Q, Sun Q, Xiao J. Telocytes in cardiac regeneration and repair. Semin Cell Dev Biol 2016; 55: 14-21. https://doi.org/10.1016/j.semcdb.2016.01.037.

[29] Zheng Y, Li H, Manole CG, Sun A, Ge J, Wang X. Telocytes in trachea and lungs. J Cell Mol Med 2011; 15: 2262-8. https://doi.org/10.1111/j.1582-4934.2011.01404.x.

[30] Kondo A, Kaestner KH. Emerging diverse roles of telocytes. Development 2019; 146: 146. https://doi.org/10.1242/dev.175018.

[31] Liao Z, Chen Y, Duan C, Zhu K, Huang R, Zhao H, et al. Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics 2021; 11: 268-91. https://doi.org/10.7150/thno.47021.

[32] Zhou Y, Yang Y, Liang T, Hu Y, Tang H, Song D, et al. The regulatory effect of microRNA-21a-3p on the promotion of telocyte angiogenesis mediated by PI3K (p110α)/AKT/mTOR in LPS induced mice ARDS. J Transl Med 2019; 17: 427. https://doi.org/10.1186/s12967-019-02168-z.

[33] Mizuta Y, Akahoshi T, Guo J, Zhang S, Narahara S, Kawano T, et al. Exosomes from adipose tissue-derived mesenchymal stem cells ameliorate histone-induced acute lung injury by activating the PI3K/Akt pathway in endothelial cells. Stem Cell Res Ther 2020; 11: 508. https://doi.org/10.1186/s13287-020-02015-9.

[34] Yu Q, Wang D, Wen X, Tang X, Qi D, He J, et al. Adipose-derived exosomes protect the pulmonary endothelial barrier in ventilator-induced lung injury by inhibiting the TRPV4/Ca(2+) signaling pathway. Am J Physiol Lung Cell Mol Physiol 2020; 318: L723-41. https://doi.org/10.1152/ajplung.00255.2019.

[35] Xu J, Xu D, Yu Z, Fu Z, Lv Z, Meng L, et al. Exosomal miR-150 partially attenuated acute lung injury by mediating microvascular endothelial cells and MAPK pathway. Biosci Rep 2022; 42: BSR20203363. https://doi.org/10.1042/BSR20203363.

[36] Shen K, Wang X, Wang Y, Jia Y, Zhang Y, Wang K, et al. miR-125b-5p in adipose derived stem cells exosome alleviates pulmonary microvascular endothelial cells ferroptosis via Keap1/Nrf2/GPX4 in sepsis lung injury. Redox Biol 2023; 62: 102655. https://doi.org/10.1016/j.redox.2023.102655.

[37] Qin J, Xu Q. Functions and application of exosomes. Acta Pol Pharm 2014; 71: 537-43.

[38] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science 2020; 367: eaau6977. https://doi.org/10.1126/science.aau6977.

[39] Fabri-Faja N, Calvo-Lozano O, Dey P, Terborg RA, Estevez MC, Belushkin A, et al. Early sepsis diagnosis via protein and miRNA biomarkers using a novel point-of-care photonic biosensor. Anal Chim Acta 2019; 1077: 232-42. https://doi.org/10.1016/j.aca.2019.05.038.

[40] Wang Z, Guo Z, Wang X, Liao H, Chen F, Liu Y, et al. Reduning alleviates sepsis-induced acute lung injury by reducing apoptosis of pulmonary microvascular endothelial cells. Front Immunol 2023; 14: 1196350. https://doi.org/10.3389/fimmu.2023.1196350.

[41] Simmons S, Erfinanda L, Bartz C, Kuebler WM. Novel mechanisms regulating endothelial barrier function in the pulmonary microcirculation. J Physiol 2019; 597: 997-1021. https://doi.org/10.1113/JP276245.